Cullinan Oncology
CGEM
CGEM
88 hedge funds and large institutions have $473M invested in Cullinan Oncology in 2022 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 26 increasing their positions, 23 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
9% more funds holding
Funds holding: 81 → 88 (+7)
1.25% more ownership
Funds ownership: 82.65% → 83.9% (+1.2%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
88
Holding in Top 10
4
Calls
$358K
Puts
$8K
Top Buyers
| 1 | +$27.4M | |
| 2 | +$15M | |
| 3 | +$7.81M | |
| 4 |
BlackRock
New York
|
+$5.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.04M |
Top Sellers
| 1 | -$18.1M | |
| 2 | -$15.1M | |
| 3 | -$10.4M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$7.78M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$6.83M |